| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding | |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | Entrez:930 MIM:107265 HGNC:HGNC:1633 Ensembl:ENSG00000177455 AllianceGenome:HGNC:1633 | |
| Description | CD19 molecule | |||||
| GTO ID | GTC1087 |
| Trial ID | CTRI/2021/04/032727 |
| Disease | Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | HCAR19 |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | It is a study to test a new type of treatment for blood cancer. In this new treatment the blood cells of patients are changed so that they cam kill cancer cell on their own. |
| Year | 2021 |
| Country | India |
| Company sponsor | Tata Memorial Hospital Research Administrative Council |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||
|
|||||||||